.. boston cio of the year® orbie® awards.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. http://ndaviesco.com/Banahan-mother-of-Buckovitch-from-Fiesole?Kurkowski=185